| Price | 9.20p on 22-04-2026 at 08:38:07 |
|---|---|
| Change | -0.30p -3.16% |
| Buy | 9.30p |
| Sell | 9.10p |
| Last Trade: | Buy 53.00 at 9.30p |
| Day's Volume: | 266,830 |
| Last Close: | 9.50p |
| Open: | 9.50p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.20p - 9.50p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £98.29m |
| VWAP: | 9.268923p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 53 | 9.30p | SI Trade |
09:37:33 - 22-Apr-26 |
| Sell* | 111,044 | 9.215p | Ordinary |
09:37:29 - 22-Apr-26 |
| Buy* | 4,506 | 9.30p | Ordinary |
08:55:21 - 22-Apr-26 |
| Buy* | 25,000 | 9.30p | Ordinary |
08:54:11 - 22-Apr-26 |
| Buy* | 325 | 9.30p | SI Trade |
08:53:06 - 22-Apr-26 |
| Sell* | 10,000 | 9.245p | Ordinary |
08:52:54 - 22-Apr-26 |
| Sell* | 107,527 | 9.30p | Ordinary |
08:46:54 - 22-Apr-26 |
| Unknown* | 232 | 9.50p | Ordinary |
08:42:11 - 22-Apr-26 |
| Buy* | 773 | 9.70p | SI Trade |
08:28:17 - 22-Apr-26 |
| Buy* | 15 | 9.70p | SI Trade |
08:28:17 - 22-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
